Abstract
Abstract. Vitamin B12, a water-soluble vitamin, plays a vital role in the formation of hematopoietic stem cells and has been associated with oral mucosal diseases, mainly recurrent aphthous stomatitis (RAS). The latter is a debilitating condition, and B12 was proposed as a potential treatment given its role in regenerating oral mucosal tissue. There is conflicting evidence that B12 deficiency causes RAS. Five of the seven randomized controlled trials reviewed used the inactive form of B12 (cyanocobalamin) as intervention, while the other two used the active form (methylcobalamin). Of the latter two, buccal discs (500 μg B12) showed significant improvement and reduced perceived pain in 77% of the subjects, and submucosal injections showed a significant difference in pain, starting from the second day. Moreover, three studies administered vitamin B12 sublingually with different dosages, which revealed that the higher dose (1000 μg) achieved a significant reduction in outbreaks, number, and duration of ulcers, especially after six months. Multivitamins showed no difference in new RAS episodes and duration. Injectable B12 was compared with the oral form, and nearly 50% of the injection group reported a desired response by the eighth week. An ointment form (500 μg) showed a significant reduction in pain levels after two days of treatment. Based on the available literature, we suggest that a daily dose of 1000 μg of vitamin B12 sublingually for six months can be used to treat RAS. Nevertheless, this conclusion should be considered tentative due to the lack of high quality, large scale studies.
References
1 Clinical manifestations and diagnosis of vitamin B12 and folate deficiency. UpToDate [Internet]. Waltham, MA: UpToDate [cited 2020 Apr 13] Available from: https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-vitamin-b12-and-folate-deficiency
2 . A Review of Vitamin B12 in Dermatology. Am J Clin Dermatol. 2015;16(1):27–33.
3 . Severe aphthous stomatitis secondary to vitamin B12 deficiency with isotretinoin therapy. JAAD Case Rep. 2019;5(6):563–5.
4 . Recurrent aphthous stomatitis – Etiology, serum autoantibodies, anemia, hematinic deficiencies, and management. J Formos Med Assoc. 2019;118(9):1279–89.
5 . Reduced dietary intake of vitamin B12 and folate in patients with recurrent aphthous stomatitis. J Oral Pathol Med. 2010;39(5):420–3.
6 . Recurrent aphthae: treatment with vitamin B12, folic acid, and iron. Br Med J. 1975;2(5969):490–3.
7 Multivitamin therapy for recurrent aphthous stomatitis: a randomized, double-masked, placebo-controlled trial. J Am Dent Assoc. (1939). 2012,;143(4):370–6.
8 . Impact of haematologic deficiencies on recurrent aphthous ulceration: a meta-analysis. Br Dent J. 2015;218(4):E8.
9 . A case report of pernicious anemia and recurrent aphthous stomatitis. J Contemp Dent Pract. 2009;10(2):83–9.
10 . Oral vitamin B(12) versus intramuscular vitamin B(12) for vitamin B(12) deficiency. Cochrane Database Syst Rev. 2018;3(3):Cd004655.
11 . Aphthous ulceration. N Eng J Med. 2006;355(2):165–72.
12 . Recurrent aphthous ulcers today: a review of the growing knowledge. Int J Oral Maxillofac Surg. 2004;33(3):221–34.
13 . Treatment of recurrent aphthous stomatitis. A literature review. J Clin Exp Dent. 2014;6(2):e168–e74.
14 . Recurrent aphthous stomatitis: current concepts in diagnosis and management. J Ind Acad Oral Med Radio. 2011;23(3):232–6.
15 . Guideline for the diagnosis and treatment of recurrent aphthous stomatitis for dental practitioners. J Int Oral Health. 2015;7(5):74–80.
16 . Case report: Recurrent aphthous stomatitis responds to vitamin B12 treatment. Can Fam Physician. 2005;51(6):844–5.
17 . Recurrent aphthous stomatitis: A review. Biomed Pharmacol J. 2013;6(1):17.
18 . Etiology and pathophysiology of recurrent aphthous stomatitis: A review. Int J Curr Res. 2014;6(10):16.
19 , Vitamin B12 for the treatment of recurrent aphthous stomatits. JKCD. 2011;1(2):87–90.
20 Effectiveness of vitamin B12 in treating recurrent aphthous stomatitis: a randomized, double-blind, placebo-controlled trial. J Am Board Fam Med. 2009;22(1):9–16.
21 . Oral aphthosis: management gaps and recent advances. Ann Acad Med Singapore. 2012;41(10):463–70.
22 . [Treatment of chronically recurrent aphthae with vitamin B12]. Zahnarztl Welt. 1954;9(3):58–9.
23 . Comparing the effect of injectable vitamin B with conventional oral treatment on aphthous stomatitis. J Skin Stem Cell. 2018;5(1–2):e69052.
24 . The effectiveness of vitamin B12 for relieving pain in Aphthous ulcers: a randomized, double-blind, placebo-controlled trial. Pain Manag Nurs. 2015;16(3):182–7.
25 . Effect of bioactive B12 in adhering discs on aphthous ulcers. Inside Dent. 2008;4(9):60–4.
26 . The effectiveness of submucosal injection bioactive vitamin B12 in comparison to triaminolone in pain and frequency of apthous ulcer. Ann Dent Spec. 2017;5(3):122.
27 . Cyanocobalamin may be beneficial in the treatment of recurrent aphthous ulcers even when vitamin B12 levels are normal. Am J Med Sci. 2008;336(5):379–82.
28 . Serum vitamin B12, folate, and iron levels in recurrent aphthous ulceration. Oral Surg Oral Med Oral Pathol. 1982;54(5):517–20.
29 . Serum iron, ferritin, folic acid, and vitamin B12 levels in recurrent aphthous stomatitis. J Eur Acad Dermatol Venereol. 2002;16(1):66–7.
30 . Recurrent aphthous stomatitis: investigation of possible etiologic factors. Am J Otolaryngol. 2006;27(4):229–32.
31 . Haematological parameters and recurrent aphthous stomatitis. J Coll Physicians Surg Pak. 2013;23(2):124–7.
32 . Haematinic deficiencies and patient clinical profiles in Polish patients with recurrent aphthous stomatitis (RAS). J Oral Pathol Med. 2018;47(5):531–7.
33 . Hematinic deficiencies in patients with recurrent aphthous stomatitis: variations by gender and age. Med Oral Patol Oral Cir Bucal. 2018;23(2):e161.
